Defence Therapeutics Inc. (DTC) — Net Asset Quality Index
Defence Therapeutics Inc. (DTC) has a Net Asset Quality Index of -89.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.37 Million minus total liabilities of €2.59 Million yields net assets of €-1.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Defence Therapeutics Inc. to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Defence Therapeutics Inc. Net Asset Quality Index Over Time (2020–2024)
This chart shows how Defence Therapeutics Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of December 2025, the index stands at -89.4%, representing net assets of €-1.22 Million against total assets of €1.37 Million EUR. Explore Defence Therapeutics Inc. (DTC) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Defence Therapeutics Inc. (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Defence Therapeutics Inc. from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Defence Therapeutics Inc. stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -750.2% | €-3.58 Million | €477.75K | €4.06 Million | ▼ -794.6 pp |
| 2023 | 44.3% | €1.57 Million | €3.53 Million | €1.97 Million | ▲ +98.2 pp |
| 2022 | -53.9% | €-387.56K | €719.67K | €1.11 Million | ▼ -151.7 pp |
| 2021 | 97.8% | €5.49 Million | €5.61 Million | €122.26K | ▲ +0.3 pp |
| 2020 | 97.5% | €1.86 Million | €1.91 Million | €48.35K | — |